Yinhang Biotech completed a new round of financing exceeding 100 million yuan.

Recently, domestic synthetic biology enterprise "Pilot Bio" completed a new round of financing exceeding 100 million yuan, jointly invested by CICC Capital, Xingxiang Capital, Caixin Capital, and Jiashan Industry. The funds will be mainly used to accelerate the commercialization of new products and expand the global market. It is understood that Pilot Bio relies on an AI-driven synthetic biology technology platform, has developed a number of original technologies with international competitiveness, and established a rich product pipeline. In the future, the company will deepen the layout of "R & D - production - supply", speed up the launch of new products, and provide economical and environmentally friendly biomanufacturing products and solutions globally.